BR100 Decreased By (-0.12%)
BR30 Increased By (0.06%)
KSE100 Increased By (0.04%)
KSE30 Increased By (0.03%)
AGHA 7.36 Decreased By ▼ -0.20 (-2.65%)
BECO 5.09 No Change ▼ 0.00 (0%)
BML 56.10 Increased By ▲ 1.12 (2.04%)
BOP 32.84 Decreased By ▼ -0.14 (-0.42%)
CNERGY 10.34 Increased By ▲ 0.24 (2.38%)
CSIL 5.07 Decreased By ▼ -0.06 (-1.17%)
FCCL 51.85 Increased By ▲ 0.60 (1.17%)
FFL 16.25 Increased By ▲ 0.07 (0.43%)
FNEL 1.20 Increased By ▲ 0.01 (0.84%)
KEL 7.18 Increased By ▲ 0.12 (1.7%)
KOSM 5.92 Increased By ▲ 0.38 (6.86%)
LOTCHEM 26.96 Decreased By ▼ -2.16 (-7.42%)
MLCF 89.50 Increased By ▲ 0.68 (0.77%)
NBP 194.99 Decreased By ▼ -2.50 (-1.27%)
NCPL 55.61 Increased By ▲ 0.59 (1.07%)
NPL 64.83 Decreased By ▼ -0.05 (-0.08%)
OGDC 312.40 Increased By ▲ 0.45 (0.14%)
PACE 10.28 Increased By ▲ 0.07 (0.69%)
PAEL 40.70 Decreased By ▼ -0.29 (-0.71%)
PIBTL 15.95 Decreased By ▼ -0.01 (-0.06%)
PPL 212.70 Increased By ▲ 0.04 (0.02%)
PRL 53.51 Increased By ▲ 0.97 (1.85%)
PTC 69.00 Decreased By ▼ -0.08 (-0.12%)
SSGC 24.85 Decreased By ▼ -0.25 (-1%)
TBL 9.52 Decreased By ▼ -0.10 (-1.04%)
TELE 8.35 Increased By ▲ 0.03 (0.36%)
TPL 18.05 Increased By ▲ 0.30 (1.69%)
TPLP 12.98 Decreased By ▼ -0.24 (-1.82%)
TREET 21.44 Decreased By ▼ -0.30 (-1.38%)
TRG 59.75 Increased By ▲ 2.86 (5.03%)
Pakistan

Novartis donates RS41.25mn to PRCS for the fight against COVID-19 pandemic

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas m
Published Updated
  • Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Novartis donated PKR 41.25 Million to Pakistan Red Crescent Society (PRCS), one of the largest humanitarian organizations in the country to support in efforts against COVID-19.

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Dr. Imran Rasheed, Chief Executive Officer, Novartis Pharma Pakistan, said, “Novartis Pakistan feels proud to stand with our Healthcare Professionals at their hour of need and hope to mitigate and contain this deadly infection as soon as humanly possible. Novartis has always remained on the forefront when it comes to Corporate Social Responsibility.

In Pakistan, we have ongoing projects in collaboration with government, NGOs and other partners working actively for the benefits of patients. We have the biggest Oncology Access program in Pakistan, providing cancer medicines free of cost, worth billions of rupees. During this challenging time of COVID-19 Pandemic, with this donation, Novartis contributing back to the society is core to our strategy and one of the pillars of Novartis vision”.

Comments

Comments are closed for this article.